Karo Expands Intimate Health Offering With Bayer's Proctosedyl

Sweden's Karo has struck its second deal in six months bringing in the Proctosedyl hemorrhoid brand from Bayer.

M&A
• Source: Shutterstock

Karo Healthcare has expanded its OTC offering in Italy with the acquisition of hemorrhoid treatment Proctosedyl from Bayer for an undisclosed sum.

Under the terms of the asset deal, Karo gains exclusive license to the Proctosedyl trademark in Italy, as well as...

More from Deals

More from Business

Haleon Takes Full Control Of China JV

 
• By 

Haleon finalizes deal to make its China joint venture a wholly-owned subsidiary in move to "drive category growth in one of the fastest growing OTC markets globally."

Perrigo Combines Americas, International Leads Into Global Post In Latest Move To Boost Results

 

Roberto Khoury, Perrigo’s international lead for a year, moves to CCO while his counterpart for the Americas region appointed in September 2023, Catherine "Triona" Schmelter, is leaving with her post eliminated in the firm’s changes.

Scope Launches Eyelid-Friendly Eye Cream In The UK

 
• By 

Eyelids have the "thinnest, most sensitive skin on the body" and are "highly prone to dehydration," which is why Scope has launched new Optase Life Sensitive Eye Daily Renewal Cream.